Flow cytometric evaluation of CD38 expression levels in the newly diagnosed T-cell acute lymphoblastic leukemia and the effect of chemotherapy on its expression in measurable residual disease, refractory disease and relapsed disease: an implication for anti-CD38 immunotherapy

BACKGROUND: Recently, anti-CD38 monoclonal antibody (Mab) therapy has become a focus of attention as an additional/alternative option for many hematological neoplasms including T-cell acute lymphoblastic leukemia (T-ALL). It has been shown that antitumor efficacy of anti-CD38-Mab depends on the leve...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:J Immunother Cancer
Main Authors: Tembhare, Prashant Ramesh, Sriram, Harshini, Khanka, Twinkle, Chatterjee, Gaurav, Panda, Devasis, Ghogale, Sitaram, Badrinath, Yajamanam, Deshpande, Nilesh, Patkar, Nikhil V, Narula, Gaurav, Bagal, Bhausaheb, Jain, Hasmukh, Sengar, Manju, Khattry, Navin, Banavali, Shripad, Gujral, Sumeet, Subramanian, Papagudi G
Formato: Artigo
Idioma:Inglês
Publicado em: BMJ Publishing Group 2020
Assuntos:
Basic Tumor Immunology
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC7247386/
https://ncbi.nlm.nih.gov/pubmed/32439800
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1136/jitc-2020-000630
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados